anything to look forward to between now and Q2 Earnings?
seems like Aegr is dead money for now, since sales and becoming profitable by Q4 are the only real indicators of the company's success/failures that we have to look forward to. Maybe some phase trial data from Japan? Seems like this is dead money for now and a long term play
How about double revenue? Company still supports $180 to $200 MILLION in revenue for 2014, that is a beautiful thing and certainly worth investing for considering estimates are double that next year and almost double 2015 in 2016. That would intrinsically put the stock way over $100, so yes, there is something to look forward to if you can see the forest through now and Q2 earnings. An undervalued stock should rise to expectations and this had not, so this would be one of those rare opportunities i guess....do you have the balls?
The pretty worthless CEO (Marc Beer) seems to see worth, suddenly, in $AEGR. He minions seem to follow suit (instead of firing him) so I would expect them to do the same. Also, the corrective active cNBC video is supposed to be out this month. May, certainly, is getting long in the tooth so that could be a bump. The end of the resolve of the FDA warning letter and an end of the DOJ investigation (with possible fines) are other possibilities.